Transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and chronic kidney disease: a

Maneeth Mylavarapu1, Israel Garcia2, Niharika Tanwar3

  • 1Department of Public Health, Adelphi University, NY, USA.

PubMed

Insights

Transcatheter aortic valve replacement (TAVR) shows better outcomes than Surgical aortic valve replacement (SAVR) for patients with aortic stenosis and chronic kidney disease, including lower mortality and fewer complications. However, TAVR increases risks for pacemaker implantation and vascular issues.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Interventional Cardiology

Background:

  • Aortic stenosis (AS) management involves Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR).
  • Limited data exist on postoperative outcomes for AS patients with co-existing Chronic Kidney Disease (CKD).

Purpose of the Study:

  • To compare the postoperative clinical outcomes of TAVR versus SAVR in patients diagnosed with AS and CKD.

Main Methods:

  • A systematic literature search was performed following PRISMA guidelines across PubMed, EMBASE, Scopus, and Google Scholar.
  • Included studies compared TAVR and SAVR clinical outcomes specifically in patients with CKD.
  • Meta-analysis of 23 studies involving 69,017 patients.

Main Results:

  • TAVR was associated with significantly lower in-hospital mortality (OR 0.54), acute kidney injury (AKI) (OR 0.41), AKI requiring dialysis (OR 0.66), and overall postoperative complications (OR 0.34) compared to SAVR.
  • TAVR also showed a significant reduction in AKI incidence (P < 0.00001) and postoperative complications (P < 0.0001).
  • Conversely, TAVR had significantly higher odds of permanent pacemaker implantation (PPI) (OR 2.69) and major vascular complications (OR 2.56) than SAVR.

Conclusions:

  • In patients with AS and CKD, TAVR demonstrates superior outcomes regarding in-hospital mortality, AKI incidence, and postoperative complications compared to SAVR.
  • TAVR is linked to increased risks of PPI and major vascular complications, necessitating individualized risk assessment.
  • TAVR represents a favorable alternative to SAVR for carefully selected CKD patients with AS.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
54
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85